TrialBMC endocrine disorders2020

Efficacy and safety of lanreotide autogel compared with lanreotide 40 mg prolonged release in Chinese patients with active acromegaly: results from a phase 3, prospective, randomized, and open-label study (LANTERN).

Zhenmei An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.